Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Benign Prostatic Hyperplasia Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Benign Prostatic Hyperplasia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Benign Prostatic Hyperplasia Treatment Overall Market Size
2.1 Global Benign Prostatic Hyperplasia Treatment Market Size: 2021 VS 2028
2.2 Global Benign Prostatic Hyperplasia Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Benign Prostatic Hyperplasia Treatment Players in Global Market
3.2 Top Global Benign Prostatic Hyperplasia Treatment Companies Ranked by Revenue
3.3 Global Benign Prostatic Hyperplasia Treatment Revenue by Companies
3.4 Top 3 and Top 5 Benign Prostatic Hyperplasia Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Benign Prostatic Hyperplasia Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Benign Prostatic Hyperplasia Treatment Players in Global Market
3.6.1 List of Global Tier 1 Benign Prostatic Hyperplasia Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Benign Prostatic Hyperplasia Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Benign Prostatic Hyperplasia Treatment Market Size Markets, 2021 & 2028
4.1.2 Drug Class
4.1.3 Minimally Invasive Surgeries
4.1.4 Laser Therapy
4.1.5 Others
4.2 By Type - Global Benign Prostatic Hyperplasia Treatment Revenue & Forecasts
4.2.1 By Type - Global Benign Prostatic Hyperplasia Treatment Revenue, 2017-2022
4.2.2 By Type - Global Benign Prostatic Hyperplasia Treatment Revenue, 2023-2028
4.2.3 By Type - Global Benign Prostatic Hyperplasia Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Benign Prostatic Hyperplasia Treatment Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Specialty Clinics
5.1.5 Others
5.2 By Application - Global Benign Prostatic Hyperplasia Treatment Revenue & Forecasts
5.2.1 By Application - Global Benign Prostatic Hyperplasia Treatment Revenue, 2017-2022
5.2.2 By Application - Global Benign Prostatic Hyperplasia Treatment Revenue, 2023-2028
5.2.3 By Application - Global Benign Prostatic Hyperplasia Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Benign Prostatic Hyperplasia Treatment Market Size, 2021 & 2028
6.2 By Region - Global Benign Prostatic Hyperplasia Treatment Revenue & Forecasts
6.2.1 By Region - Global Benign Prostatic Hyperplasia Treatment Revenue, 2017-2022
6.2.2 By Region - Global Benign Prostatic Hyperplasia Treatment Revenue, 2023-2028
6.2.3 By Region - Global Benign Prostatic Hyperplasia Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Benign Prostatic Hyperplasia Treatment Revenue, 2017-2028
6.3.2 US Benign Prostatic Hyperplasia Treatment Market Size, 2017-2028
6.3.3 Canada Benign Prostatic Hyperplasia Treatment Market Size, 2017-2028
6.3.4 Mexico Benign Prostatic Hyperplasia Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Benign Prostatic Hyperplasia Treatment Revenue, 2017-2028
6.4.2 Germany Benign Prostatic Hyperplasia Treatment Market Size, 2017-2028
6.4.3 France Benign Prostatic Hyperplasia Treatment Market Size, 2017-2028
6.4.4 U.K. Benign Prostatic Hyperplasia Treatment Market Size, 2017-2028
6.4.5 Italy Benign Prostatic Hyperplasia Treatment Market Size, 2017-2028
6.4.6 Russia Benign Prostatic Hyperplasia Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Benign Prostatic Hyperplasia Treatment Market Size, 2017-2028
6.4.8 Benelux Benign Prostatic Hyperplasia Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Benign Prostatic Hyperplasia Treatment Revenue, 2017-2028
6.5.2 China Benign Prostatic Hyperplasia Treatment Market Size, 2017-2028
6.5.3 Japan Benign Prostatic Hyperplasia Treatment Market Size, 2017-2028
6.5.4 South Korea Benign Prostatic Hyperplasia Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Benign Prostatic Hyperplasia Treatment Market Size, 2017-2028
6.5.6 India Benign Prostatic Hyperplasia Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Benign Prostatic Hyperplasia Treatment Revenue, 2017-2028
6.6.2 Brazil Benign Prostatic Hyperplasia Treatment Market Size, 2017-2028
6.6.3 Argentina Benign Prostatic Hyperplasia Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Benign Prostatic Hyperplasia Treatment Revenue, 2017-2028
6.7.2 Turkey Benign Prostatic Hyperplasia Treatment Market Size, 2017-2028
6.7.3 Israel Benign Prostatic Hyperplasia Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Benign Prostatic Hyperplasia Treatment Market Size, 2017-2028
6.7.5 UAE Benign Prostatic Hyperplasia Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Benign Prostatic Hyperplasia Treatment Major Product Offerings
7.1.4 Abbott Benign Prostatic Hyperplasia Treatment Revenue in Global Market (2017-2022)
7.1.5 Abbott Key News
7.2 Allergan plc
7.2.1 Allergan plc Corporate Summary
7.2.2 Allergan plc Business Overview
7.2.3 Allergan plc Benign Prostatic Hyperplasia Treatment Major Product Offerings
7.2.4 Allergan plc Benign Prostatic Hyperplasia Treatment Revenue in Global Market (2017-2022)
7.2.5 Allergan plc Key News
7.3 Astellas Pharma
7.3.1 Astellas Pharma Corporate Summary
7.3.2 Astellas Pharma Business Overview
7.3.3 Astellas Pharma Benign Prostatic Hyperplasia Treatment Major Product Offerings
7.3.4 Astellas Pharma Benign Prostatic Hyperplasia Treatment Revenue in Global Market (2017-2022)
7.3.5 Astellas Pharma Key News
7.4 Asahi Kasei Corporation
7.4.1 Asahi Kasei Corporation Corporate Summary
7.4.2 Asahi Kasei Corporation Business Overview
7.4.3 Asahi Kasei Corporation Benign Prostatic Hyperplasia Treatment Major Product Offerings
7.4.4 Asahi Kasei Corporation Benign Prostatic Hyperplasia Treatment Revenue in Global Market (2017-2022)
7.4.5 Asahi Kasei Corporation Key News
7.5 Boehringer Ingelheim GmbH
7.5.1 Boehringer Ingelheim GmbH Corporate Summary
7.5.2 Boehringer Ingelheim GmbH Business Overview
7.5.3 Boehringer Ingelheim GmbH Benign Prostatic Hyperplasia Treatment Major Product Offerings
7.5.4 Boehringer Ingelheim GmbH Benign Prostatic Hyperplasia Treatment Revenue in Global Market (2017-2022)
7.5.5 Boehringer Ingelheim GmbH Key News
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Corporate Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Benign Prostatic Hyperplasia Treatment Major Product Offerings
7.6.4 GlaxoSmithKline Benign Prostatic Hyperplasia Treatment Revenue in Global Market (2017-2022)
7.6.5 GlaxoSmithKline Key News
7.7 Pfizer
7.7.1 Pfizer Corporate Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Benign Prostatic Hyperplasia Treatment Major Product Offerings
7.7.4 Pfizer Benign Prostatic Hyperplasia Treatment Revenue in Global Market (2017-2022)
7.7.5 Pfizer Key News
7.8 Sanofi
7.8.1 Sanofi Corporate Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Benign Prostatic Hyperplasia Treatment Major Product Offerings
7.8.4 Sanofi Benign Prostatic Hyperplasia Treatment Revenue in Global Market (2017-2022)
7.8.5 Sanofi Key News
7.9 Teva Pharmaceutical Industries
7.9.1 Teva Pharmaceutical Industries Corporate Summary
7.9.2 Teva Pharmaceutical Industries Business Overview
7.9.3 Teva Pharmaceutical Industries Benign Prostatic Hyperplasia Treatment Major Product Offerings
7.9.4 Teva Pharmaceutical Industries Benign Prostatic Hyperplasia Treatment Revenue in Global Market (2017-2022)
7.9.5 Teva Pharmaceutical Industries Key News
7.10 Merck
7.10.1 Merck Corporate Summary
7.10.2 Merck Business Overview
7.10.3 Merck Benign Prostatic Hyperplasia Treatment Major Product Offerings
7.10.4 Merck Benign Prostatic Hyperplasia Treatment Revenue in Global Market (2017-2022)
7.10.5 Merck Key News
7.11 Boston Scientific Corporation
7.11.1 Boston Scientific Corporation Corporate Summary
7.11.2 Boston Scientific Corporation Business Overview
7.11.3 Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Major Product Offerings
7.11.4 Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Revenue in Global Market (2017-2022)
7.11.5 Boston Scientific Corporation Key News
7.12 Teleflex Incorporated
7.12.1 Teleflex Incorporated Corporate Summary
7.12.2 Teleflex Incorporated Business Overview
7.12.3 Teleflex Incorporated Benign Prostatic Hyperplasia Treatment Major Product Offerings
7.12.4 Teleflex Incorporated Benign Prostatic Hyperplasia Treatment Revenue in Global Market (2017-2022)
7.12.5 Teleflex Incorporated Key News
7.13 Endo International
7.13.1 Endo International Corporate Summary
7.13.2 Endo International Business Overview
7.13.3 Endo International Benign Prostatic Hyperplasia Treatment Major Product Offerings
7.13.4 Endo International Benign Prostatic Hyperplasia Treatment Revenue in Global Market (2017-2022)
7.13.5 Endo International Key News
7.14 Urologix
7.14.1 Urologix Corporate Summary
7.14.2 Urologix Business Overview
7.14.3 Urologix Benign Prostatic Hyperplasia Treatment Major Product Offerings
7.14.4 Urologix Benign Prostatic Hyperplasia Treatment Revenue in Global Market (2017-2022)
7.14.5 Urologix Key News
7.15 LISA Laser
7.15.1 LISA Laser Corporate Summary
7.15.2 LISA Laser Business Overview
7.15.3 LISA Laser Benign Prostatic Hyperplasia Treatment Major Product Offerings
7.15.4 LISA Laser Benign Prostatic Hyperplasia Treatment Revenue in Global Market (2017-2022)
7.15.5 LISA Laser Key News
7.16 Olympus
7.16.1 Olympus Corporate Summary
7.16.2 Olympus Business Overview
7.16.3 Olympus Benign Prostatic Hyperplasia Treatment Major Product Offerings
7.16.4 Olympus Benign Prostatic Hyperplasia Treatment Revenue in Global Market (2017-2022)
7.16.5 Olympus Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer